Community support program to improve lung cancer screening adherence
Community Support Program for Lung Cancer Screening Volume II
This study tests whether a community support program can help people in West Philadelphia keep their lung cancer screening appointments by providing transportation and scheduling help.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | Abramson Cancer Center at Penn Medicine Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06628167 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance adherence to lung cancer screening guidelines in West Philadelphia by implementing a community support program. The initiative focuses on individuals within the Penn Medicine healthcare system who have upcoming or missed low dose CT screenings. Participants will receive assistance with transportation to their appointments and support in scheduling their screenings. The goal is to demonstrate the effectiveness of these interventions in increasing screening rates in an urban setting.
Who should consider this trial
Good fit: Ideal candidates are Philadelphia residents who have upcoming or missed low dose CT screenings for lung cancer.
Not a fit: Patients who live outside the Philadelphia city limits will not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly increase lung cancer screening adherence, leading to earlier detection and better patient outcomes.
How similar studies have performed: Similar community-based interventions have shown promise in improving adherence to cancer screening guidelines, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Upcoming or missed low dose CT for lung cancer screening * Philadelphia resident Exclusion Criteria: * Lives outside Philadelphia city limits
Where this trial is running
Philadelphia, Pennsylvania
- Univeristy of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Farouk Dako, MD — farouk.dako@pennmedicine.upenn.edu
- Study coordinator: Farouk Dako
- Email: farouk.dako@pennmedicine.upenn.edu
- Phone: 2673091241
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.